Bengt Åstrand
Research Subjects
Bengt Åstrand has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Göran Petersson
Health Institute, Department of Medicine and Optometry, Linnaeus University, Kalmar, Sweden
2 shared publications - Anders Ekedahl
R&D department, National Corporation of Swedish Pharmacies (Apoteket AB), Apoteket Lejonet, Stortorget 8, SE-211 34 Malmö, Sweden
1 shared publication - Bo Hovstadius
Associate professor, research fellow. eHealth Institute, Department of Medicine and Optometry, Linnaeus University . Kalmar ( Sweden ).
1 shared publication - Emelie Montelius
1eHealth Institute, School of Human Sciences, University of Kalmar, Kalmar, Sweden
1 shared publication
Latest Publications
- Open Access
- 27 May 2009
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 9 (1) , 11
Dispensed drugs and multiple medications in the Swedish population: an individual-based register study
Multiple medications is a well-known potential risk factor in terms of patient's health. The aim of the present study was to estimate the prevalence of dispensed drugs and multiple medications in an entire national population, by using individual based data on dispensed drugs.
- 27 May 2009
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 9 (1) , 11
Open AccessDispensed drugs and multiple medications in the Swedish population: an individual-based register study
Multiple medications is a well-known potential risk factor in terms of patient's health. The aim of the present study was to estimate the prevalence of dispensed drugs and multiple medications in an entire national population, by using individual based data on dispensed drugs.
- 12 May 2009
- Published by S. Karger AG in Chemotherapy
- Vol. 55 (4) , 215-220
Avoiding Drug-Drug Interactions
Background: Drugs may be prescribed in combinations causing drug-drug interactions (DDI) and adverse drug reactions (ADR), resulting in hospital care. Methods: To provide prescribers of drug therapy with a better knowledge of individuals’ current drug therapy, governments have started to collect prescribing data. Results: The data on individuals’ dispensed drugs is available for prescribers, pharmacists, and the registered individuals in Sweden and Denmark. The information has not yet come to an extensive use in healthcare. Pilot projects have been reported positively, but accessibility has to be improved. Conclusions: To avoid DDIs, reliable information on all drugs used by each single individual needs to be available at the point of care. Knowledge databases about clinically relevant DDIs must be updated and accurate. To tailor the magic bullet for the individual, new genomic- and proteomic-based knowledge about the individual has to be considered in the future.
- 12 May 2009
- Published by S. Karger AG in Chemotherapy
- Vol. 55 (4) , 215-220
Avoiding Drug-Drug Interactions
Background: Drugs may be prescribed in combinations causing drug-drug interactions (DDI) and adverse drug reactions (ADR), resulting in hospital care. Methods: To provide prescribers of drug therapy with a better knowledge of individuals’ current drug therapy, governments have started to collect prescribing data. Results: The data on individuals’ dispensed drugs is available for prescribers, pharmacists, and the registered individuals in Sweden and Denmark. The information has not yet come to an extensive use in healthcare. Pilot projects have been reported positively, but accessibility has to be improved. Conclusions: To avoid DDIs, reliable information on all drugs used by each single individual needs to be available at the point of care. Knowledge databases about clinically relevant DDIs must be updated and accurate. To tailor the magic bullet for the individual, new genomic- and proteomic-based knowledge about the individual has to be considered in the future.
- Open Access
- 26 January 2009
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 9 (1) , 8
Assessment of ePrescription quality: an observational study at three mail-order pharmacies
The introduction of electronic transfer of prescriptions (ETP) or ePrescriptions in ambulatory health care has been suggested to have a positive impact on the prescribing and dispensing processes. Thereby, implying that ePrescribing can improve safety, quality, efficiency, and cost-effectiveness. In December 2007, 68% of all new prescriptions were transferred electronically in Sweden. The aim of the present study was to assess the quality of ePrescriptions by comparing the proportions of ePrescriptions and non-electronic prescriptions necessitating a clarification contact (correction, completion or change) with the prescriber at the time of dispensing.
- 26 January 2009
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 9 (1) , 8
Open AccessAssessment of ePrescription quality: an observational study at three mail-order pharmacies
The introduction of electronic transfer of prescriptions (ETP) or ePrescriptions in ambulatory health care has been suggested to have a positive impact on the prescribing and dispensing processes. Thereby, implying that ePrescribing can improve safety, quality, efficiency, and cost-effectiveness. In December 2007, 68% of all new prescriptions were transferred electronically in Sweden. The aim of the present study was to assess the quality of ePrescriptions by comparing the proportions of ePrescriptions and non-electronic prescriptions necessitating a clarification contact (correction, completion or change) with the prescriber at the time of dispensing.